anti-Retinoic Acid Receptor Responder (Tazarotene Induced) 3 (RARRES3) Anticorps

Retinoids exert biologic effects such as potent growth inhibitory and cell differentiation activities and are used in the treatment of hyperproliferative dermatological diseases. De plus, nous expédions Retinoic Acid Receptor Responder (Tazarotene Induced) 3 Protéines (4) et Retinoic Acid Receptor Responder (Tazarotene Induced) 3 Kits (2) et beaucoup plus de produits pour cette protéine.

afficher tous les anticorps Gène GeneID UniProt
RARRES3 5920 Q9UL19
RARRES3    
RARRES3    
Comment commander chez anticorps-enligne
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Commandez enligne
  • orders@anticorps-enligne.fr

Top anti-Retinoic Acid Receptor Responder (Tazarotene Induced) 3 Anticorps sur anticorps-enligne.fr

Showing 10 out of 71 products:

Catalogue No. Reactivité Hôte Conjugué Application Images Quantité Livraison Prix Détails
Humain Lapin Inconjugué IHC, WB Human Stomach 100 μL 2 to 3 Days
$229.00
Détails
Humain Chèvre Inconjugué ELISA, IHC   100 μg 6 to 7 Days
$429.84
Détails
Humain Chèvre Inconjugué ELISA, IHC, IHC (p) Anti-RARRES3 antibody IHC staining of human placenta. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody  ABIN1103911 concentration 27454 ug/ml. Anti-RARRES3 antibody IHC of human placenta. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody concentration 3.75 ug/ml. 50 μg 11 to 14 Days
$484.00
Détails
Humain Lapin Inconjugué IHC, IHC (p), WB 100 μL 11 to 14 Days
$493.17
Détails
Humain Lapin Inconjugué ELISA, WB Western blot analysis of RARRES3 using HeLa whole cell lysates Western blot analysis of extracts from 293, using RARRES3 Antibody. 100 μL 11 to 12 Days
$390.77
Détails
Humain Lapin Inconjugué WB WB Image Sample(30 μg of whole cell lysate) A:Raji, B:MOLT4, 12% SDS PAGE antibody diluted at 1:1000 100 μL 3 to 4 Days
$466.18
Détails
Humain Lapin Inconjugué WB Western blot analysis in NCI-H292 cell line lysates (35ug/lane). 400 μL 2 to 3 Days
$515.63
Détails
Humain Lapin Inconjugué WB Western blot analysis of extracts of 293T cells, using RARRES3 antibody. 100 μL 11 to 13 Days
$366.77
Détails
Humain Lapin Inconjugué IHC, ELISA, WB 100 μL 2 to 3 Days
$446.88
Détails
Humain Lapin Inconjugué ELISA, WB   100 μL 11 to 13 Days
$335.04
Détails

anti-Retinoic Acid Receptor Responder (Tazarotene Induced) 3 Anticorps mieux référencés

  1. Human Polyclonal RARRES3 Primary Antibody pour ELISA - ABIN548234 : Tsai, Shyu, Jiang: RIG1 suppresses Ras activation and induces cellular apoptosis at the Golgi apparatus. dans Cellular signalling 2007 (PubMed)

  2. Human Polyclonal RARRES3 Primary Antibody pour ELISA, WB - ABIN5952721 : Ahmad, Ali, Lebastchi, Qin, Lo, Yakimov, Khan, Choy, Geirsson, Pober, Tellides et al.: IFN-gamma primes intact human coronary arteries and cultured coronary smooth muscle cells to double-stranded RNA- and self-RNA-induced inflammatory responses by upregulating TLR3 and melanoma ... dans Journal of immunology (Baltimore, Md. : 1950) 2010 (PubMed)

Plus d’anticorps contre Retinoic Acid Receptor Responder (Tazarotene Induced) 3 partenaires d’interaction

Human Retinoic Acid Receptor Responder (Tazarotene Induced) 3 (RARRES3) interaction partners

  1. we observed frameshift mutations of RARRES3 in 11 cases of colorectal cancer

  2. Identified the tumor suppressor RARRES3 as a critical target of G9a. Epigenetic silencing of RARRES3 contributed to the tumor-promoting function of G9a

  3. this study indicated that increased expression of TIG3 in primary glioblastoma is a novel biomarker for predicting poor outcome of patients. We then hypothesize that TIG3 may function in a different pattern in glioblastoma

  4. Overexpression of TIG3 suppresses tumor growth in hepatocellular carcinoma

  5. Letter: Interleukin-22 inhibits tazarotene-induced gene 3 expression in keratinocytes via MAPK-ERK1/2 and JAK2/STAT3 signaling.

  6. findings provide a new insight into the molecular link between p53, protein acylation and Wnt/beta-catenin signaling whereby RARRES3 plays a pivotal role in modulating the acylation status of signaling proteins.

  7. the flexible main loop of H-REV107, but not that of TIG3, is critical for its NTD to modulate its CTD in inducing cell death.

  8. RARRES3 downregulation engages metastasis-initiating capabilities by facilitating adhesion of the tumor cells to the lung parenchyma.

  9. These findings argue that TIG3 is involved in the control of keratinocyte differentiation and that loss of TIG3 in transformed cells contributes to the malignant phenotype.

  10. We show that the C-terminal hydrophobic domain targets intact TIG3 to the plasma membrane, but when isolated as an independent element localizes at the mitochondria and a segment of the N-terminal hydrophilic region targets the centrosome.

  11. Low RIG1 expression is associated with testis cancer.

  12. RIG1 gene is a downstream target of p53 in cancer cell lines

  13. Data suggest that pericentrosomal localization of TIG3 is a key event that results in microtubule and microfilament redistribution and pericentrosomal organelle clustering and that leads to cancer cell apoptosis.

  14. We conclude that TG1-catalysed cross-linking, regulated by TIG3, might play an important role in the formation of neuronal tau inclusions in certain tauopathies

  15. induction of TIG3 is associated with the suppression of anchorage-independent growth in certain aerodigestive tract cancer cells

  16. TIG3 facilitates the terminal stages in keratinocyte differentiation via activation of type I transglutaminase

  17. altered RARRES3 expression may play a role in the carcinogenesis of the liver and biliary tract.

  18. identification and characterization of the functional RA response element that is responsible for the RA-mediated induction of RIG1 gene

  19. TIG3 is negatively regulated by an activated MEK-ERK signaling pathway in ovarian carcinoma.

  20. The proapoptotic and anti-RAS activities of RIG1 are primarily associated with the Golgi localization of the protein.

Retinoic Acid Receptor Responder (Tazarotene Induced) 3 (RARRES3) profil antigène

Profil protéine

Retinoids exert biologic effects such as potent growth inhibitory and cell differentiation activities and are used in the treatment of hyperproliferative dermatological diseases. These effects are mediated by specific nuclear receptor proteins that are members of the steroid and thyroid hormone receptor superfamily of transcriptional regulators. RARRES1, RARRES2, and RARRES3 are genes whose expression is upregulated by the synthetic retinoid tazarotene. RARRES3 is thought act as a tumor suppressor or growth regulator.

Gene names and symbols associated with RARRES3

  • retinoic acid receptor responder 3 (RARRES3) anticorps
  • retinoic acid receptor responder (tazarotene induced) 3 L homeolog (rarres3.L) anticorps
  • zgc:92249 (zgc:92249) anticorps
  • HRASLS4 anticorps
  • HRSL4 anticorps
  • MGC68773 anticorps
  • PLA1/2-3 anticorps
  • RARRES3 anticorps
  • RIG1 anticorps
  • TIG3 anticorps

Protein level used designations for RARRES3

HRAS-like suppressor 4 , RAR-responsive protein TIG3 , retinoic acid receptor responder protein 3 , retinoic acid-inducible gene 1 , retinoid-inducible gene 1 protein , tazarotene-induced gene 3 protein , retinoic acid receptor responder (tazarotene induced) 3

GENE ID SPECIES
5920 Homo sapiens
398865 Xenopus laevis
436896 Danio rerio
451277 Pan troglodytes
483772 Canis lupus familiaris
Fournisseurs de qualité sélectionnés pour anti-Retinoic Acid Receptor Responder (Tazarotene Induced) 3 (RARRES3) Anticorps
Avez-vous cherché autre chose?